NDC 69423-598 Bodewell Psoriasis Calming
Salicylic Acid Cream Topical - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 69423 - The Procter & Gamble Manufacturing Company
- 69423-598 - Bodewell Psoriasis Calming
Product Packages
NDC Code 69423-598-23
Package Description: 237 mL in 1 TUBE
NDC Code 69423-598-59
Package Description: 59 mL in 1 TUBE
Product Details
What is NDC 69423-598?
What are the uses for Bodewell Psoriasis Calming?
What are Bodewell Psoriasis Calming Active Ingredients?
- SALICYLIC ACID 2 g/100mL - A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions.
Which are Bodewell Psoriasis Calming UNII Codes?
The UNII codes for the active ingredients in this product are:
- SALICYLIC ACID (UNII: O414PZ4LPZ)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are Bodewell Psoriasis Calming Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SMILAX ARISTOLOCHIIFOLIA ROOT (UNII: NR100Y25G0)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- SANGUINARIA CANADENSIS ROOT (UNII: N9288CD508)
- SAMBUCUS NIGRA WHOLE (UNII: 4X6JT95SYN)
- SCROPHULARIA NODOSA (UNII: 7H443NUB2T)
- POPULUS ALBA BARK (UNII: K12723D3GV)
- SODIUM PYRROLIDONE CARBOXYLATE (UNII: 469OTG57A2)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- POPULUS TREMULOIDES BARK (UNII: 5543O0CEID)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
- HAMAMELIS VIRGINIANA TOP (UNII: UDA30A2JJY)
- ACHILLEA MILLEFOLIUM WHOLE (UNII: 2FXJ6SW4PK)
- WATER (UNII: 059QF0KO0R)
- ACHILLEA MILLEFOLIUM SEED (UNII: 8V0N54LMLR)
- ALCOHOL (UNII: 3K9958V90M)
- ALTHAEA OFFICINALIS ROOT (UNII: TRW2FUF47H)
- BERBERIS VULGARIS ROOT BARK (UNII: 1TH8Q20J0U)
- CAPRYLYL GLYCOL (UNII: 00YIU5438U)
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)
- SAFFLOWER OIL (UNII: 65UEH262IS)
- MATRICARIA RECUTITA FLOWERING TOP (UNII: 3VNC7T6Z02)
- COCONUT OIL (UNII: Q9L0O73W7L)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- GLYCERIN (UNII: PDC6A3C0OX)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- PETROLATUM (UNII: 4T6H12BN9U)
- TROLAMINE (UNII: 9O3K93S3TK)
- TUSSILAGO FARFARA LEAF (UNII: G2GH7V846Z)
- VINCETOXICUM HIRUNDINARIA ROOT (UNII: 9R858U917W)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- LENS CULINARIS FRUIT (UNII: ZYZ076G9JH)
- NIACINAMIDE (UNII: 25X51I8RD4)
- PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG)
- VERONICA OFFICINALIS WHOLE (UNII: 9EHR580PSP)
- MALVA SYLVESTRIS LEAF (UNII: 17H39B00T5)
- NASTURTIUM OFFICINALE LEAF (UNII: 362629QKRT)
- PIMPINELLA SAXIFRAGA WHOLE (UNII: LCL1491142)
What is the NDC to RxNorm Crosswalk for Bodewell Psoriasis Calming?
- RxCUI: 317152 - salicylic acid 2 % Topical Cream
- RxCUI: 317152 - salicylic acid 20 MG/ML Topical Cream
* Please review the disclaimer below.
Patient Education
Salicylic Acid Topical
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or birthmarks. Salicylic acid is in a class of medications called keratolytic agents. Topical salicylic acid treats acne by reducing swelling and redness and unplugging blocked skin pores to allow pimples to shrink. It treats other skin conditions by softening and loosening dry, scaly, or thickened skin so that it falls off or can be removed easily.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".